Turn Therapeutics Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Turn Therapeutics Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-55.4×Operating cash was negative last year, while some debt falls due within a year.
Lower than 75% of Healthcare companies in United States.
Cash Cushion Ratio
+2%Cash, after subtracting all debt, equals 2% of its market value (net cash).
Lower than 65% of Healthcare companies in United States.
Tangible Assets Ratio
92%Of every $100 the company owns, $92 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 65% of Healthcare companies in United States.
Tangible Net Worth Ratio
80%Of every $100 of net worth, $80 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 62% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Turn Therapeutics Inc. made a loss over the last year. Turn Therapeutics Inc. owes $0.96 for every $1 it owns. Turn Therapeutics Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTurn Therapeutics Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
450.06The share price is 450.06 times Turn Therapeutics Inc.'s book value per share, higher than almost all Healthcare companies in United States.
Market cap
$309 MThe total market value of all of Turn Therapeutics Inc.'s shares at today's price (share price × number of shares), smaller than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$1 MWhat Turn Therapeutics Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.02Net worth divided by the number of shares. The share price of $10.18 is 450.1 times this, which is the P/B above.
Return on equity (ROE)
-686.3%Turn Therapeutics Inc. lost 686.3% of its shareholders' money over the last year, lower than 95% of Healthcare companies in United States.
Owes vs Owns
0.96×Turn Therapeutics Inc. owes $0.96 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.
Dividend yield
NoneTurn Therapeutics Inc. does not currently pay a dividend.
Profit growth
LossTurn Therapeutics Inc. made a loss in each of the last two years.
Cash vs debt
Net cashTurn Therapeutics Inc. held $5 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Turn Therapeutics Inc.: $309 M ÷ $1 M (30 Jun 2026) = 450.1.
What is Turn Therapeutics Inc.'s return on equity?
Turn Therapeutics Inc. lost 686.3% of its shareholders' money over the last year, lower than 95% of Healthcare companies in United States.
How much does Turn Therapeutics Inc. owe compared with what it owns?
Turn Therapeutics Inc. owes $0.96 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.
Does Turn Therapeutics Inc. pay a dividend?
No. Turn Therapeutics Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.